![William T. Symonds](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William T. Symonds
Directeur Général chez
Enzyvant Therapeutics GmbH
Profil
William T.
Symonds is Chief Executive Officer at Enzyvant Therapeutics GmbH since 2022.
Dr. Symonds is Director, Chief Executive & Development Officer at Altavant Sciences, Inc. since 2018.
Dr. Symonds was Chief Executive Officer at Enzyvant, Inc. from 2022 to 2023.
Dr. Symonds was Executive Director & Chief Development Officer at Arbutus Biopharma Corp.
from 2015 to 2018.
Dr. Symonds was Director at Arbutus Biopharma, Inc. from 2014 to 2015.
Dr. Symonds was Director-Antiviral Clinical Pharmacology at GlaxoSmithKline LLC.
Dr. Symonds was Vice President-Liver Disease Therapeutic at Gilead Sciences, Inc. in 2014.
Dr. Symonds was Senior Vice President-Clinical Pharmacology at Pharmasset, Inc. in 2012.
Dr. Symonds was Chief Development Officer at Roivant Sciences GmbH.
Dr. Symonds was Chief Development Officer at Roivant Sciences, Inc. Dr. Symonds earned a doctorate from Campbell University.
Postes actifs de William T. Symonds
| Sociétés | Poste | Début |
|---|---|---|
Enzyvant Therapeutics GmbH
 Enzyvant Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which focuses on developing treatments for rare diseases | Directeur Général | 01/01/2022 |
Anciens postes connus de William T. Symonds
| Sociétés | Poste | Fin |
|---|---|---|
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur Général | 01/06/2023 |
| ARBUTUS BIOPHARMA CORPORATION | Directeur/Membre du Conseil | 22/10/2018 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Corporate Officer/Principal | 01/07/2018 |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Directeur/Membre du Conseil | 01/03/2015 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/04/2014 |
Formation de William T. Symonds
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
49
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Health Technology |
Campbell University
 Campbell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Enzyvant, Inc.
Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops life-saving medicines for patients with rare respiratory diseases | Health Technology |
Enzyvant Therapeutics GmbH
Enzyvant Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which focuses on developing treatments for rare diseases | Commercial Services |
